We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Ameriprise Financial
AMP
$49.2B
| $9.26M | 0.01% |
+20,192
| New | +$9.25M |
|
|
ODTX
1052
Odyssey Therapeutics
ODTX
$1.3B
| $9.22M | 0.01% |
+492,697
| New | +$8.64M |
|
1053
Buckle
BKE
$2.16B
| $9.22M | 0.01% |
218,376
+119,733
| +121% | +$5.92M |
|
1054
Box
BOX
$4.71B
| $9.2M | 0.01% |
346,834
-2,283,320
| -87% | -$57M |
|
1055
Amtech Systems
ASYS
$271M
| $9.2M | 0.01% |
398,564
-18,512
| -4% | -$352K |
|
1056
CALL
Citigroup
C
$229B
| $9.2M | 0.01% |
65,700
+61,700
| +1,543% | +$8.03M |
|
1057
Maravai LifeSciences
MRVI
$1.07B
| $9.18M | 0.01% |
1,471,477
-609,857
| -29% | -$2.63M |
|
1058
Collegium Pharmaceutical
COLL
$761M
| $9.17M | 0.01% |
253,353
-495,459
| -66% | -$16.9M |
|
1059
Barclays
BCS
$89.8B
| $9.14M | 0.01% |
340,142
-47,626
| -12% | -$1.15M |
|
1060
Essential Utilities
WTRG
$11.9B
| $9.12M | 0.01% |
237,937
+191,237
| +410% | +$7.3M |
|
1061
AvePoint
AVPT
$2.79B
| $9.09M | 0.01% |
811,095
+440,772
| +119% | +$4.53M |
|
|
1062
Mercado Libre
MELI
$97.7B
| $9.05M | 0.01% |
5,334
-309,260
| -98% | -$528M |
|
1063
DNOW Inc
DNOW
$2.92B
| $9.04M | 0.01% |
697,138
-1,169,976
| -63% | -$15.2M |
|
1064
Eton Pharmaceutcials
ETON
$1.7B
| $9.02M | 0.01% |
249,182
+166,461
| +201% | +$4.88M |
|
|
NBIS
1065
Nebius Group N.V.
NBIS
$66.3B
| $9.02M | 0.01% |
32,645
-27,412
| -46% | -$5.43M |
|
1066
PUT
Uber
UBER
$149B
| $8.95M | 0.01% |
124,000
-537,300
| -81% | -$39.4M |
|
1067
Okta
OKTA
$29.3B
| $8.94M | 0.01% |
65,534
-357,203
| -84% | -$33.6M |
|
1068
Terreno Realty
TRNO
$7.2B
| $8.94M | 0.01% |
+137,988
| New | +$9.02M |
|
1069
Banco Santander Chile
BSAC
$16.7B
| $8.88M | 0.01% |
269,717
-136,459
| -34% | -$4.41M |
|
1070
Coca-Cola Consolidated
COKE
$12.5B
| $8.84M | 0.01% |
46,313
+14
| +0% | +$2.61K |
|
|
ACH
1071
Accendra Health
ACH
$84.6M
| $8.83M | 0.01% |
2,582,579
+821,575
| +47% | +$2.55M |
|
1072
Lincoln Educational Services
LINC
$787M
| $8.83M | 0.01% |
176,926
-356,601
| -67% | -$16.1M |
|
1073
CALL
Western Digital
WDC
$172B
| $8.81M | 0.01% |
13,800
-8,100
| -37% | -$3.94M |
|
|
AVNS
1074
DELISTED
Avanos Medical
AVNS
| $8.81M | 0.01% |
+354,231
| New | +$8.29M |
|
1075
United States Antimony
UAMY
$814M
| $8.75M | 0.01% |
1,205,386
+1,141,865
| +1,798% | +$10.3M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.